drugset / Trial / NCT03749356
Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety and of Once-Daily Tacrolimus (TacroBell SR Cap.) in patients who received renal transplantation.
Timeline
- Start
- 2018-09-05
- Primary completion
- 2020-07-30
- Completion
- 2020-12-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TacroBell SR cap. | Unknown | 0.2 mg/kg | Oral |
Indications
No indication recorded.